Course Description

This training program provides comprehensive knowledge of the modern, lifecycle-based approach to pharmaceutical process validation. It moves beyond the traditional “three-batch mentality” and establishes the scientific, risk-based framework needed to design, qualify, and continuously verify robust manufacturing processes.

The curriculum is built on the three-stage framework: Process Design, Process Qualification, and Continued Process Verification. The program integrates Quality by Design principles, Quality Risk Management, and Knowledge Management into validation practices. Practical examples for both large- and small-molecule products are included.

Scope

This program applies to the following pharmaceutical manufacturing processes:

• Drug substances and drug products (sterile and non-sterile)
• Biotechnological and biological products, including vaccines
• Active Pharmaceutical Ingredients
• Radiopharmaceuticals and veterinary drugs
• New and existing commercial manufacturing processes

The program does not cover medical devices, dietary supplements, or ancillary operations such as cleaning and sterilization validation.

Target Audience

This program is designed for:

• Process development scientists and engineers
• Manufacturing and production personnel
• Quality assurance and quality control managers
• Regulatory affairs specialists
• Validation engineers and specialists
• Technical services and technology transfer teams
• Auditors and compliance officers

Regulatory References Used to Design This Program

This training program is based on the principles and expectations outlined in the following regulatory guidelines and industry technical reports:

• US FDA Guidance for Industry: Process Validation: General Principles and Practices
• EMA Guideline on Process Validation for medicinal products for human and veterinary use
• ICH Guideline Q8 (R2): Pharmaceutical Development
• ICH Guideline Q9: Quality Risk Management
• ICH Guideline Q10: Pharmaceutical Quality Systems
• ICH Guideline Q11: Development and Manufacture of Drug Substances
• ICH Guideline Q6A and Q6B: Specifications
• EU GMP Annex 15: Qualification and Validation
• PDA Technical Report No. 60: Process Validation: A Lifecycle Approach
• ASTM Standards including E2500, E2537, E2709, and E2810

Certification

Learners who successfully complete the program will receive a dated, traceable certificate that provides verifiable proof of their achievement for professional records.